1.中山大学附属第六医院妇科,广东 广州 510655
2.广州市黄埔区中六生物医学创新研究院,广东 广州 510655
3.顺德区第三人民医院妇产科,广东 顺德 528300
4.中山大学附属第六医院粤西医院//信宜市人民医院妇科, 广东 茂名 525300
李锦波,第一作者,研究方向:子宫内膜异位症的基础及临床,E-mail:lijb28@mail.sysu.edu.cn
纸质出版日期:2024-03-20,
收稿日期:2024-01-08,
录用日期:2024-03-11
扫 描 看 全 文
李锦波,李雪云,吴福丽等.改良式左炔诺孕酮宫内缓释系统固定治疗子宫腺肌病[J].中山大学学报(医学科学版),2024,45(02):290-296.
LI Jinbo,LI Xueyun,WU Fuli,et al.Modified Fixation of Levonorgestrel-releasing Intrauterine System for the Treatment of Adenomyosis[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(02):290-296.
李锦波,李雪云,吴福丽等.改良式左炔诺孕酮宫内缓释系统固定治疗子宫腺肌病[J].中山大学学报(医学科学版),2024,45(02):290-296. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240314.001.
LI Jinbo,LI Xueyun,WU Fuli,et al.Modified Fixation of Levonorgestrel-releasing Intrauterine System for the Treatment of Adenomyosis[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(02):290-296. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240314.001.
目的
2
介绍改良式左炔诺孕酮宫内缓释系统(LNG-IUS)固定方法,探讨其在治疗既往曾发生LNG-IUS脱落的子宫腺肌病患者中的作用。
方法
2
收集2022年6月至2023年6月因LNG-IUS脱落在3个医疗机构接受改良式LNG-IUS固定的22例子宫腺肌病患者的资料,分析患者的术前病例特征、术中术后并发症及术后LNG-IUS下移或脱落情况,比较术前、术后3月及术后6月患者痛经及月经量的变化。
结果
2
22例患者平均手术时间(19.51±7.41)min,术中出血(6.71±5.30)mL。13例患者在局部麻醉下进行,9例患者在静脉麻醉下进行。4例患者由住院医生完成,15例患者由主治医师完成,余3例由副主任及以上医师完成。所有患者未发生术中、术后并发症。平均随访时间11.51月,随访期间无患者再次发生LNG-IUS脱落。患者术后1月血红蛋白平均水平显著高于术前(
P
<
0.001)。术后3月及术后6月疼痛评分及月经失血图评分均比术前显著改善(
P
<
0.001)。
结论
2
改良式LNG-IUS固定是治疗既往发生LNG-IUS脱落的子宫腺肌病患者安全、有效的方法,可有效避免再次发生LNG-IUS脱落。改良式LNG-IUS固定操作简便,可在各级医疗机构中由各级医师施行,具有临床推广价值。
Objective
2
To introduce a fixation technique with the modified levonorgestrel-releasing intrauterine system (LNG-IUS) and evaluate its efficacy in the treatment of adenomyosis patients with previous LNG-IUS expulsion.
Methods
2
A retrospective analysis was done on 22 adenomyosis patients who underwent modified LNG-IUS fixation due to LNG-IUS expulsion at three hospitals from June 2022 to June 2023. The baseline clinical characteristics, operative and postoperative details were collected and analyzed. The Visual analogu scale (VAS) scores and pictorial blood loss assessment chart (PBAC) scores were measured and compared before, 3 and 6 months after the LNG-IUS fixation.
Results
2
The mean operative time was (19.51±7.41) min and intraoperative bleeding was (6.71±5.30) mL. Of the patients, 13 were operated under local anaesthesia and the other 9 under intravenous anaesthesia. There were 4 operations performed by a resident doctor, 15 by an attending doctor and 3 by a senior doctor. No intraoperative or postoperative complication was found. The mean follow-up was 11.51 months and no patient had a recurrence of LNG-IUS expulsion during the follow-up period. The mean level of hemoglobin at 1 month after operation was significantly higher than that before (
P
<
0.001). VAS scores and PBAC scores at 3 and 6 months postoperatively were all improved significantly than those preoperatively (
P
<
0.001).
Conclusions
2
Effectively preventing the recurrence of LNG-IUS expulsion, modified LNG-IUS fixation is a safe and efficient method for adenomyosis patients with previous LNG-IUS expulsion. Modified LNG-IUS fixation deserves the clinical application due to its easy operation and wide range of use on women.
左炔诺孕酮宫内缓释系统子宫腺肌病改良式固定月经过多痛经
levonorgestrel-releasing intrauterine system (LNG-IUS)adenomyosismodified fixationmenorrhagiadysmenorrhea
中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
Endometriosis Professional Committee of the Obstetricians and Gynecologists Branch of the Chinese Medical Association. Chinese experts' consensus on diagnosis and treatment of adenomyosis[J]. Chin J Obstet Gynecol, 2020, 55(6): 376-383.
郎景和, 冷金花, 邓姗, 等. 左炔诺孕酮宫内缓释系统临床应用的中国专家共识[J]. 中华妇产科杂志, 2019, 54(12): 815-825.
Lang JH, Leng JH, Deng S, et al. Chinese expert panel consensus recommendations on the clinical application of levonorgestrel-releasing intrauterine system[J]. Chin J Obstet Gynecol, 2019, 54(12): 815-825.
Abbas AM, Samy A, Atwa K, et al. The role of levonorgestrel intra-uterine system in the management of adenomyosis: a systematic review and meta-analysis of prospective studies[J]. Acta Obstet Gynecol Scand, 2020,99(5):571-581.
Anthony MS, Zhou X, Schoendorf J, et al. Demographic, reproductive, and medical risk factors for intrauterine device expulsion[J]. Obstet Gynecol, 2022, 140(6): 1017-1030.
李雷, 冷金花, 贾双征, 等. 左炔诺孕酮宫内缓释系统治疗子宫腺肌病计划外取出和脱落情况及其相关因素分析[J]. 中国实用妇科与产科杂志, 2016, 32(11):1088-1092.
Li L, Leng JH, JIA SZ, et al. Analysis of unplanned taking- out and expulsion of LNG-IUS and related factors during the treatment of symptomatic adenomyosis[J]. Chin J Pract Gynecol Obstet, 2016, 32(11): 1088-1092.
Bofill RM, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding[J]. Cochrane Database Syst Rev, 2020, 6(6): D2126.
Harada T, Ota I, Kitawaki J, et al. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: a prospective observational study (J-MIRAI)[J]. Contraception, 2022, 116: 22-28.
Momoeda M, Akira S, Harada T, et al. Quality of life of Japanese dysmenorrhea/heavy menstrual bleeding patients treated with levonorgestrel intrauterine delivery system in a real-world setting[J]. Adv Ther, 2022, 39(8): 3616-3634.
李国华, 王凤卿, 李晓芳, 等. GnRHa联合左炔诺孕酮宫内缓释系统治疗大子宫腺肌病的疗效观察[J]. 国际妇产科学杂志, 2016, 43(5): 594-597.
Li GH, Wang FQ, Li XF, et al. To observe the curative effect of GnRHa combined with levonorgestrel-releasing intrauterine system in the treatment of severe large uterine adenomyosis[J]. J Intern Obstet Gynecol, 2016, 43(5): 594-597.
Szubert M, Koziróg E, Olszak O, et al. Adenomyosis and infertility-review of medical and surgical approaches[J]. Int J Environ Res Public Health, 2021, 18(3): 1235.
Stratopoulou CA, Donnez J, Dolmans MM. Conservative management of uterine adenomyosis: medical vs. surgical approach[J]. J Clin Med, 2021, 10(21): 4878.
Yang H, Wang S, Fu X, et al. Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding[J]. J Obstet Gynaecol Res, 2022, 48(1): 161-168.
张信美,黄秀峰.子宫腺肌病手术治疗策略[J].中国实用妇科与产科杂志, 2017, 33(2): 145-148.
Zhang XM, Huang XF. Strategy of surgical treatment for adenomyosis[J]. Chin J Pract Gynecol Obstet, 2017, 33(2): 145-148.
彭超,周应芳.子宫腺肌病药物治疗选择及长期管理[J].中国实用妇科与产科杂志, 2019, 35(5): 516-519.
Peng C, Zhou YF. Drug choice in medical therapy and long-term management for patients with adenomyosis of the uterus[J]. Chin J Pract Gynecol Obstet, 2019, 35(5): 516-519.
杜洁贤, 王康, 田彩, 等. 不同预处理方式对曼月乐治疗弥漫性大子宫腺肌病效果的影响研究[J]. 中国妇幼保健, 2020, 35(2): 199-202.
Du JX, Wang K, Tian C, et al. Study on the effects of different pretreatments on curative effect of mirena in treatment of diffuse large adenomyosis[J]. Matern Child Health Care Chin, 2020, 35(2): 199-202.
Lv N, Guo J, Yuan Q, et al. Feasibility and effectiveness of hysteroscopic suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis[J]. J Minim Invasive Gynecol, 2024, 31(1): 57-63.
Zhang H, Cao B, Tong J, et al. An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis[J]. BMC Womens Health, 2022, 22(1): 451.
Zhu L, Yang X, Cao B, et al. The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis[J]. Fertil Steril, 2021, 116(4): 1191-1193.
宋小磊, 柯妍, 热娜, 等. 新型宫腔内打结法固定左炔诺孕酮宫内缓释系统的临床研究[J].中国实用妇科与产科杂志, 2023, 39(7): 745-748.
Song XL, Ke Y, Re N, et al. Clinical study on a novel intrauterine knotting method for fixing levonorgestrel intrauterine sustained-release system[J]. Chin J Pract Gynecol Obstet, 2023, 39(7): 745-748.
赖贺, 曾俐琴, 丁堪铄, 等. 两种新型LNG-IUS固定术治疗子宫腺肌病的病例报告及比较分析[J]. 中国计划生育和妇产科, 2023, 15(8): 37-41.
Lai H, Zeng LQ, Ding KS, et al. Case reports and comparative analysis of two novel LNG-IUS fixation techniques for the treatment of adenomyosis[J]. Chin J Family Planning Gynecotokol, 2023, 15(8): 37-41.
Cui H, Huang J. The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: a case report[J]. Int J Surg Case Rep, 2023, 110: 108772.
0
浏览量
8
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构